INVESTORS

100+ SKUs
Across 12 Brands
40+ COUNTRY DISTRIBUTION
Health Authority Approval in Mexico and Brazil
$46.9M 2020 REVENUE
Margins Over 75%
6 COMPANIES IN PORTFOLIO
Serving Consumer, B2B, Pharmaceutical Markets
OUR HISTORY
What Makes Us A Company of Firsts®
MORE ABOUT US
Get to Know Our Team and Portfolio
PRESS RELEASES
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant...
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
SAN DIEGO, CA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community
SAN DIEGO, CA, April 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medical Marijuana,...
MEDIA COVERAGE
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information...
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
SAN DIEGO, CA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in May 2022
SAN DIEGO, CA, June 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC:...
STOCK INFO
LAST | 0.0265 | Change | -0.0005 |
OPEN | 0.0200 | Change % | 1.85% |
HIGH | 0.0287 | 52 Week Range | 0.01-0.222 |
LOWW | 0.0200 | Day Range | 0.0200-0.0287 |
VOLUME | 15119948 | Market Cap (real-time) | N/A |
Last Updated: 08-20-2021 (US/Eastern)